NM_139242.4:c.146_153delGGGTGCTC
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_139242.4(MTFMT):c.146_153delGGGTGCTC(p.Arg49LeufsTer58) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000507 in 1,379,580 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000051 ( 0 hom. )
Consequence
MTFMT
NM_139242.4 frameshift
NM_139242.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.08
Publications
0 publications found
Genes affected
MTFMT (HGNC:29666): (mitochondrial methionyl-tRNA formyltransferase) The protein encoded by this nuclear gene localizes to the mitochondrion, where it catalyzes the formylation of methionyl-tRNA. [provided by RefSeq, Jun 2011]
MTFMT Gene-Disease associations (from GenCC):
- combined oxidative phosphorylation defect type 15Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Leigh syndrome with leukodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Pathogenic. The variant received 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-65029460-AGAGCACCC-A is Pathogenic according to our data. Variant chr15-65029460-AGAGCACCC-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 133323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MTFMT | NM_139242.4 | c.146_153delGGGTGCTC | p.Arg49LeufsTer58 | frameshift_variant | Exon 1 of 9 | ENST00000220058.9 | NP_640335.2 | |
| MTFMT | XM_005254158.6 | c.146_153delGGGTGCTC | p.Arg49LeufsTer31 | frameshift_variant | Exon 1 of 9 | XP_005254215.2 | ||
| MTFMT | XR_001751081.2 | n.172_179delGGGTGCTC | non_coding_transcript_exon_variant | Exon 1 of 5 | ||||
| MTFMT | XR_007064421.1 | n.172_179delGGGTGCTC | non_coding_transcript_exon_variant | Exon 1 of 4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MTFMT | ENST00000220058.9 | c.146_153delGGGTGCTC | p.Arg49LeufsTer58 | frameshift_variant | Exon 1 of 9 | 1 | NM_139242.4 | ENSP00000220058.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD2 exomes AF: 0.00000825 AC: 1AN: 121226 AF XY: 0.00 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
121226
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000507 AC: 7AN: 1379580Hom.: 0 AF XY: 0.00000588 AC XY: 4AN XY: 680530 show subpopulations
GnomAD4 exome
AF:
AC:
7
AN:
1379580
Hom.:
AF XY:
AC XY:
4
AN XY:
680530
show subpopulations
African (AFR)
AF:
AC:
0
AN:
28804
American (AMR)
AF:
AC:
0
AN:
34390
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24688
East Asian (EAS)
AF:
AC:
0
AN:
33730
South Asian (SAS)
AF:
AC:
0
AN:
77198
European-Finnish (FIN)
AF:
AC:
0
AN:
44532
Middle Eastern (MID)
AF:
AC:
0
AN:
5280
European-Non Finnish (NFE)
AF:
AC:
7
AN:
1073594
Other (OTH)
AF:
AC:
0
AN:
57364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.418
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
May 01, 2017
CeGaT Center for Human Genetics Tuebingen
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 19, 2024
Mayo Clinic Laboratories, Mayo Clinic
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
PP1, PM2, PM3_supporting, PVS1 -
Combined oxidative phosphorylation defect type 15 Pathogenic:1
Mar 01, 2014
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.